Comprehensive Urology Care for Advanced Practice Providers:
Mastering Inpatient and Outpatient Management


Advanced Practice Providers (APPs) are essential to delivering high-quality urologic care, and this CME/NCPD program—presented by the Fox Chase – Temple Urologic Institute—offers a focused, hands-on opportunity to deepen that expertise. Participants will gain targeted updates in general urology and urologic oncology, explore evolving diagnostic and management strategies, and strengthen procedural skills through interactive workshops and simulation-based training. Led by experienced clinicians, the program equips attendees with practical knowledge, clinical confidence, and evidence-based approaches to elevate patient care across all urologic settings.
Register Now

DATES & TIMES:
Thursday, June 11, 2026 I 7:30am – 4:00pm
Friday, June 12, 2026 I 7:30am – 5:00pm

LOCATION:
Hilton Philadelphia City Avenue
4200 City Avenue, Philadelphia, PA  19131

HOTEL ACCOMMODATIONS:
Discounted hotel accommodations are available at the Hilton City Line at a rate of $229 per night. A limited number of rooms will be held until May 25th, 2026. To make a reservation, please visit Hilton’s group reservation web site.

PROGRAM DIRECTOR

Andres F. Correa, MD
Director of Research & Associate Professor,
Department of Urology, Fox Chase Cancer Center

 

Alexander Kutikov, MD, FACS
Chair and Professor, Department of Urology;
Roberta R. Scheller Chair in Urologic Oncology,
Fox Chase Cancer Center

 

Elena Dreyzin, PA-C
Advanced Practice Provider, Department of Urology,
Fox Chase Cancer Center

 

Sarah Leach, PA-C
Advanced Practice Provider, Department of Urology,
Fox Chase Cancer Center

 

SPEAKERS FROM THE FOX CHASE – TEMPLE UROLOGIC INSTITUTE:

Christine Amoroso, BSN, RN, OCN

Joshua Cohn, MD, FPMRS

Andres F. Correa, MD

Elena Dreyzin, PA-C

Vavah Fiase, PA-C

Justin Friedlander, MD

Daniel Geynisman, MD

Eric Ghiraldi, DO

Samuel Ivan, MD

Kerri Kelly, BSN, RN-BC, CWOCN  

Marcel Knotek, PA-C

Alexander Kutikov, MD, FACS

Jeff Laarz, PA-C

Sarah Leach, PA-C

Lisa Lettieri, BSN, RN, AMB-BC 

James Ryan Mark, MD, FACS

Luz Mejia, PA-C

Christine O’Donnell, MSN, RN, CCRN, CWON

Susan Roethke, CRNP, MSN, AOCNP, ANP-BC

Jill Schreiber, PA-C

Steve Sterious, MD, FACS

Colleen Tetzlaff, PA-C

Victoria Wong, PA-C

 

AGENDA:

DAY 1 — Thursday, June 11, 2026

7:30 – 8:00 AM

Welcome, Breakfast, & Exhibit Hall

8:00 AM

Opening Remarks

8:00 – 10:00 AM

General Urology – Part One

8:00 – 8:30 AM — Anatomy & Physiology of the Genitourinary System
Elena Dreyzin, PA-C
Overview of the genitourinary system with emphasis on structures relevant to urology.

8:30 – 9:00 AM — Diagnostic Imaging in Urology
Steve Sterious, MD, FACS
Techniques and modalities: ultrasound, CT, MRI, and PET imaging. 

9:00 – 9:30 AM — Benign Urological Conditions
Eric Ghiraldi, DO
BPH diagnosis and management of male and female lower urinary tract symptoms (LUTS).

9:30 – 10:00 AM — Urolithiasis & Urinary Tract Infections
Vavah Fiase, PA-C
Dietary and medical management, surgical interventions, and special considerations in stone disease.

10:00 – 10:30 AM

Exhibit Hall Break & Refreshments

10:30 AM – 12:30 PM

General Urology – Part Two

10:30 – 11:00 AM — PSA Screening & Monitoring
Marcel Knotek, PA-C
Overview of PSA screening, monitoring strategies, and available risk-stratifying tests.

11:00 – 11:30 AM — Indication and Management of Stents, PCNs, and Role of IR in Tube Management
Justin Friedlander, MD
Management of post-op retention, post-op complications, gross hematuria, the indications and management of ureteral stents, percutaneous nephrostomy tubes (PCNs), and the role of interventional radiology (IR) in tube management.

11:30 AM – 12:00 PM — Urologic Emergencies
Sarah Leach, PA-C
Diagnosis and management of torsion, priapism, Fournier’s gangrene, penile fracture, urosepsis, trauma, and paraphimosis.

12:00 – 12:30 PM — Reconstructive Urology, Urologic Trauma & Prosthetics
Samuel Ivan, MD
Techniques of urethral stricture disease, bladder reconstruction, managing genitourinary trauma and urologic prosthetic devices including artificial urinary sphincters (AUS) and inflatable penile prostheses (IPP).

12:30 – 1:30 PM

Lunch & Exhibitor Break

1:30 – 4:00 PM

Hands-on Activities (Rotating Stations)

• Use of Ultrasound in the Office — Christine Amoroso, BSN, RN, OCN & Lisa Lettieri, BSN, RN, AMB-BC 

• BPH Management (small group case discussion)— Eric Ghiraldi, DO

• Kidney Stone Management — Diet, Supplements, and Medications (small group case discussion)— Vavah Fiase, PA-C

• Management of Foleys, Stents, Drains, & Nephrostomy Tubes —Sarah Leach, PA-C

• Urology Case Study — Jeff Laarz, PA-C

Non-Credit Session

• IPP & AUS Hands-on Simulation (this session does not qualify for AMA PRA Category 1 Credits™ or NCPD contact hours)Samuel Ivan, MD

4:00 – 4:30 PM

Closing Remarks

 

DAY 2 — Friday, June 12, 2026

7:30 – 8:00 AM

Welcome, Breakfast, & Exhibit Hall

8:00 AM

Opening Remarks

8:00 – 10:30 AM

Urologic Oncology – Part One

8:00 – 8:30 AM — Pelvic Floor Dysfunction: Diagnosis & Management
Joshua Cohn, MD, FPMRS
Focus on male and female pelvic floor disorders, including diagnosis and therapeutic approaches.

8:30 – 9:00 AM — Testicular & Penile Cancers
Daniel Geynisman, MD
Diagnosis, staging, treatment options, and survivorship strategies.

9:00 – 9:30 AM — Prostate Cancer Imaging & Biopsy Techniques
Alexander Kutikov, MD, FACS
Review of prostate imaging (MRI and ultrasound), biopsy methods (TRUS, MRI-guided biopsy, etc.) and decision-making in management.

9:30 – 10:00 AM — Prostate Cancer Management: Localized
Andres F. Correa, MD
Localized prostate cancer, risk stratification, treatment, and follow-up.

10:00 – 10:30 AM — Prostate Cancer Management: Metastatic
Victoria Wong, PA-C
Management of metastatic prostate cancer and review of important tests that should be checked.

10:30 – 11:00 AM

Exhibit Hall Break & Refreshments

11:00 AM – 12:30 PM

Urologic Oncology – Part Two

11:00– 11:30 AM — Urothelial Carcinoma: Localized
James Ryan Mark, MD, FACS
Management of bladder cancer (NMIBC and MIBC), upper tract urothelial carcinoma (UTUC) and urinary diversion.

11:30 – 12:00 PM — Kidney Cancer: Localized
Jill Schreiber, PA-C
Diagnosis, staging, treatment options, and follow-up.

12:00 – 12:30 PM — Systemic Treatments for Urothelial and Renal Cancers
Susan Roethke, CRNP, MSN, AOCNP, ANP-BC
Overview of common systemic therapies and identification of associated emergent and adverse effects.

12:30 – 1:30 PM

Lunch & Exhibit Hall Break

1:30 – 4:00 PM

Hands-on Activities (Rotating Stations)

• Wound/Ostomy Nurse Demonstrations — Kerri Kelly, BSN, RN-BC, CWOCN & Christine O’Donnell, MSN, RN, CCRN, CWON

• Imaging in Uro-Oncology (small group discussion) — James Ryan Mark, MD, FACS

• Management of Elevated PSA (small group discussion) — Luz Mejia, PA-C

• Management of Uro-Oncology Medication Side Effects (small group discussion) — Colleen Tetzlaff, PA-C

• Gross Hematuria Management — Foley Selection and Bladder Irrigation — Sarah Leach, PA-C

Non-Credit Session

• Cystoscopy Demonstration (This session does not qualify for AMA PRA Category 1 Credits™ or NCPD contact hours)  — Elena Dreyzin, PA-C

4:00 – 4:30 PM

Closing Remarks

 

INTENDED AUDIENCE:
The program is designed for advanced practice providers including physician assistants and nurse practitioners involved in the treatment of patients with genitourinary disorders.

ACCREDITATION STATEMENT:
The Temple Health Office for Continuing Medical Education is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians. Fox Chase Cancer Center is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

DESIGNATION STATEMENT:
The Temple Health Office for Continuing Medical Education designates this live activity for a maximum of 13 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the educational activity. Fox Chase Cancer Center designates this live activity for a maximum of 13 Hour(s) NCPD (ANCC Contact Hours). Participants should claim only the credit commensurate with the extent of their participation in the activity.

INQUIRIES:
Lucía Tono, PhD, MEd

Register Now

Fox Chase Cancer Center (FCCC) reserves the right to cancel, change or postpone any course due to unforeseen circumstances. In the event of cancellations or postponement, FCCC is not responsible for any related costs, charges or expenses to participants, including cancellation costs incurred by airlines/travel agencies. All dates are subject to change due to weather, room availability, or other unforeseen circumstances.


Published

January 23, 2026

Expires

June 12, 2026